Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for QuidelOrtho Corporation (QDEL : NSDQ)

• Company Description    QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. Number of Employees: 6,600

• Price / Volume Information    Yesterday's Closing Price: $28.56 Daily Weekly Monthly 20 Day Moving Average: 722,823 shares Shares Outstanding: 67.93 (millions) Market Capitalization: $1,940.12 (millions) Beta: 0.59 52 Week High: $49.45 52 Week Low: $19.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.66% 2.83% 12 Week 1.78% 0.14% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9975 SUMMERS RIDGE ROAD - SAN DIEGO,CA 92121 USA ph: 858-552-1100 fax: 858-453-4338 ir@quidelortho.com http://www.quidelortho.com

• General Corporate Information    Officers Brian J. Blaser - Chief Executive Officer and President Kenneth F. Buechler - Chairman Joseph M. Busky - Chief Financial Officer John R. Chiminski - Director Evelyn S. Dilsaver - Director Peer Information QuidelOrtho Corporation (BJCT) QuidelOrtho Corporation (CADMQ) QuidelOrtho Corporation (APNO) QuidelOrtho Corporation (UPDC) QuidelOrtho Corporation (IMTIQ) QuidelOrtho Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 219798105 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/11/26 Share - Related Items Shares Outstanding: 67.93 Most Recent Split Date: (:1) Beta: 0.59 Market Capitalization: $1,940.12 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.81 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.56 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/11/26

• Fundamental Ratios P/E Current FY Estimate: 11.16 Trailing 12 Months: 12.47 PEG Ratio: - Price Ratios Price/Book: 0.95 Price/Cash Flow: 0.80 Price / Sales: 0.71 EPS Growth vs. Year Ago Period: -5.88% vs. Previous Quarter: 566.67% Sales Growth vs. Year Ago Period: -3.74% vs. Previous Quarter: 14.01% ROE 12/31/25 - - 09/30/25 - 5.75 06/30/25 - 5.29 ROA 12/31/25 - - 09/30/25 - 2.49 06/30/25 - 2.43 Current Ratio 12/31/25 - - 09/30/25 - 1.78 06/30/25 - 1.12 Quick Ratio 12/31/25 - - 09/30/25 - 0.98 06/30/25 - 0.62 Operating Margin 12/31/25 - - 09/30/25 - 5.72 06/30/25 - 5.77 Net Margin 12/31/25 - - 09/30/25 - -42.53 06/30/25 - -16.10 Pre-Tax Margin 12/31/25 - - 09/30/25 - -41.86 06/30/25 - -14.89 Book Value 12/31/25 - - 09/30/25 - 29.98 06/30/25 - 41.13 Inventory Turnover 12/31/25 - - 09/30/25 - 2.51 06/30/25 - 2.57 Debt-to-Equity 12/31/25 - - 09/30/25 - 1.23 06/30/25 - 0.74 Debt-to-Capital 12/31/25 - - 09/30/25 - 55.08 06/30/25 - 42.59

Powered by Zacks Investment Research ©